Economic Impact of Drugs De-Funding and Pharmaceutical Co-Payment

Value in Health - United Kingdom
doi 10.1016/j.jval.2014.08.1002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Economic Impact Associated With Pharmaceutical Interventions in Cardiovascular Disease

Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
2017English

Governments’ Payment Discipline: The Macroeconomic Impact of Public Payment Delays and Arrears

Journal of Macroeconomics
EconomicsEconometrics
2016English

Payment Restrictions for Prescription Drugs Under Medicaid

PharmacoEconomics
Health PolicyPublic HealthOccupational HealthPharmacologyEnvironmental
1992English

Co-Payment(Co-Financing) Patiens Diagnosed With Arterial Hipertension and Dislipidemia

2019English

The Economic Sociology of Digitalised Payment Services

Przegląd Socjologiczny
2019English

How Pharmaceutical Industry Funding Affects Trial Outcomes: Causal Structures and Responses

Social Science and Medicine
MedicinePhilosophy of ScienceHealthHistory
2008English

Economic Impact of the End of the Market Exclusivity for Orphan Drugs

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Pharmaceutical Co-Crystals With Isonicotinamide

Acta Crystallographica Section A Foundations of Crystallography
2012English

Funding of Pensions and Economic Growth: Are They Really Related?

Journal of Pension Economics and Finance
Organizational BehaviorEconomicsEconometricsHuman Resource ManagementFinance
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy